Invitrogen to Acquire Applied Biosystems

It’s always interesting to speculate on the long-term marketplace ramifications of an acquisition. The pending acquisition of Applied Biosystems by Invitrogen Corporation this Fall marks Invitrogen’s move to take market leadership in the area of biotechnology reagents and systems.

Invitrogen is hoping that this strategic combination will launch the company into global leadership in the biotechnology market since they expect to generate close to $3.5 billion in combined sales. In addition, the combined markets now give the company a major presence in key growth markets and strong technical capabilities in the areas of genetic analysis, proteomics, cell biology and cell systems. Interestingly, the name for the new combined company will be Applied Biosystems, Inc. although the corporate headquarters will remain at the Invitrogen site in Carlsbad, CA.

The Board of Directors of the new company will be composed of the nine current Invitrogen Board members and three additional members from the current Applera Board. Current Invitrogen Chairman and CEO, Gregory T. Lucier, will remain in that position for the combined company, while Mark P. Stevenson, formerly Applied Biosystems’ President and Chief Operating Officer, will carry on in that position.

"This transaction combines the industry's premier consumables provider with the industry's premier systems provider to create a world-class biotechnology tools company," Lucier claims. "With this acquisition, we are nearly doubling our consumables business as almost half of Applied Biosystems's revenues are consumable in nature. It also provides significant value creating opportunities for customers, shareholders and employees alike.".>>>

For the full article, click here.

Last updated: July 20, 2008
Contact
The LIMSource® and
LIMS/Letter® are registered
trademarks of the LIMSource,
P.O. Box 935
Kenwood, CA 95452 USA
Tel: +1 (707) 526-6885
Fax: +1 (707) 526-6889
© 1996-2008